IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis-Reference-Cited by-同舟云学术

IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis

Published:2011-11 Issue:5 Volume:128 Page:1086-1092.e3
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Wilson Todd M.,Maric Irina,Shukla Juhi,Brown Margaret,Santos Carlo,Simakova Olga,Khoury Paneez,Fay Michael P.,Kozhich Alexander,Kolbeck Roland,Metcalfe Dean D.,Klion Amy D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF;Tavernier;Cell,1991

2. Treatment of patients with the hypereosinophilic syndrome with mepolizumab;Rothenberg;N Engl J Med,2008

3. Mepolizumab and exacerbations of refractory eosinophilic asthma;Haldar;N Engl J Med,2009

4. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia;Nair;N Engl J Med,2009

5. MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function;Kolbeck;J Allergy Clin Immunol,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequence variants influencing the regulation of serum IgG subclass levels;Nature Communications;2024-09-14

2. Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma;Diagnostics;2024-06-25

3. Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis;Cytometry Part B: Clinical Cytometry;2024-04-26

4. Novel Serum Biomarkers for Patients with Allergic Asthma Phenotype;Biomedicines;2024-01-19

5. The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy;The Journal of Allergy and Clinical Immunology: In Practice;2023-09